TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
Altro Health raised $7 million in seed funding led by NFX. The startup sells software that lets gyms, personal trainers and medspas offer lab testing and clinician-prescribed treatments under their own brands; how the company will measure safety and clinical outcomes was not reported.
Altro Health has raised $7 million in seed funding for software that helps gyms, personal trainers and medspas offer lab testing and clinician-prescribed treatments under their own brands. NFX led the round, which also included Founder Collective and Primetime Partners, according to Athletech News. Altro says it will use the money for product development, hiring, and sales and marketing.
Altro describes its product as a “Shopify for wellness businesses.” The platform provides a branded storefront and patient portal, connects businesses with lab testing and prescription offerings, and handles what the company calls the clinical side. Altro says a board-certified clinical team supervises each service and that products are supplied by licensed 503A and 503B pharmacies. The source does not provide further details on the clinical team’s role in individual patient decisions.
The company says businesses can begin offering services in as few as two days and reports that more than 500 businesses are on the platform. Those figures are company-reported. The offerings cited in the report include bloodwork, peptides, GLP-1 drugs and hormone therapy. The platform lets participating businesses retain their own branding and client relationships while setting prices, according to the company.
Altro’s Starter plan is listed at $319 per month, billed quarterly. It includes a co-branded storefront and patient portal, product catalog access, remote and on-site lab testing, and pricing control. The Pro plan costs $599 per month and adds a business-domain storefront, marketing tools, premium lab panels with mobile blood draws, and priority support. Altro offers custom pricing for businesses with multiple locations.
Founder and CEO Andrea Corleto said the company chose to serve wellness businesses rather than compete directly for consumers. NFX general partner James Currier said the fund saw a consumer category without a clear leader and viewed trusted infrastructure as a key need. These are the executives’ views; the report does not provide independent market-size or demand data beyond a separate survey finding.
Gyms Add Clinical Services
The funding comes as some gyms and wellness businesses add medical services to their offerings. Altro’s approach gives smaller operators a way to present lab testing and prescription services under their own brands while relying on an outside platform for parts of the process. That could make these offerings easier for businesses to launch, though the company’s growth figures do not establish clinical effectiveness or safety.
The model also places health-related services in settings people may associate primarily with fitness. That raises practical questions about how customers distinguish coaching from medical care, who evaluates whether a treatment is appropriate, and how ongoing care is managed. Altro says its clinical team supervises services, but the report does not describe specific protocols or how responsibility is divided between the platform, clinicians, pharmacies and participating businesses.
As an affiliate, we earn on qualifying purchases.
Other Gyms Enter Health Care
Altro is entering a market where fitness businesses are already testing links with medical providers. Athletech News reports that Massachusetts gym owner Andrew Boimila offers peptides to members through provider Asher Med. In February, UFC Gym announced a joint venture with NexGen MD Scientific to open clinics offering GLP-1s, hormone replacement therapy and peptides. The initial plan covered two California locations, with expansion across the network over two years.
Life Time has offered similar services through its Miora clinics since late 2023, while Dallas-based Recess Fitness introduced RecessRx, according to the report. The examples show several arrangements: in-house clinics, joint ventures, and partnerships with outside providers. They do not establish how common these models are across the fitness industry.
A New Consumer report released this year found that one-third of younger consumers surveyed said they would consider peptides on a healthcare or wellness professional’s recommendation. The source article does not give the survey’s sample size, field dates, or a more precise age definition, so the result should be read as a limited indicator of stated interest rather than a measure of treatment use.
““Direct-to-consumer brands are fighting over the same customers, so we went after something bigger.””
— Andrea Corleto, Altro Health founder and CEO, as quoted by Athletech News
As an affiliate, we earn on qualifying purchases.
Clinical Oversight Details
The report does not disclose Altro’s valuation, the full terms of the seed round, or a detailed breakdown of investor contributions. It also does not specify how much of the $7 million will go to each planned use or set a timeline for those investments.
Questions remain about the platform’s clinical operations: the report does not explain how clinicians assess patients, monitor treatments, handle adverse events, or coordinate follow-up care. It also does not identify which specific treatments are available through each business or describe the rules governing how businesses market them. Altro says its clinical team supervises services, but further operational detail was not included.
The article cites consumer interest in peptides, but does not establish how many people are seeking or receiving these services, or whether the survey finding applies to Altro’s customers. It is also unclear how many of the more than 500 businesses reported on the platform actively offer prescription services, as opposed to other products or testing.
As an affiliate, we earn on qualifying purchases.
Altro’s Planned Expansion
Altro says it will direct the new funding toward product development, hiring, and sales and marketing. The report does not name specific product releases, hiring targets, new markets, or dates for those plans. It also does not say whether the company expects to change its pricing or service catalog.
Further updates may clarify how Altro supports clinical oversight as it expands and how many businesses use each part of the platform. For now, the company’s announced funding and stated plans mark the next development; no rollout schedule or additional financing milestone was reported.
As an affiliate, we earn on qualifying purchases.
Key Questions
How much funding did Altro Health raise?
Altro raised $7 million in seed funding, in a round led by NFX with participation from Founder Collective and Primetime Partners, according to Athletech News.
What does Altro Health’s platform do?
It gives gyms, trainers and medspas tools to offer lab testing and clinician-prescribed services through branded storefronts and patient portals. Altro says its clinical team supervises each service.
What services are mentioned in the report?
The report lists bloodwork, peptides, GLP-1 drugs and hormone therapy. The services available may vary by business; the article does not provide a complete location-by-location catalog.
What will Altro do with the funding?
The company says it plans to spend the money on product development, hiring, and sales and marketing. It has not provided a detailed allocation or timeline in the source report.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
